Affiliation:
1. Shengzhou People' Hospital
2. People’s Hospital of Lishui City
Abstract
Abstract
Objective To explore potential diagnostic and prognostic markers of cervical cancer by using GEO and TCGA databases.Methods Expression matrices related to cervical cancer were downloaded from the GEO database. Gene expression and clinical-pathological data from TCGA and GTEx were obtained from the UCSC Xena database. Differentially expressed genes (DEGs) between normal and tumor tissue samples were identified using the limma package in R. DEGs were subjected to Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses using the ClusterProfiler package. The Cox proportional hazard regression model was used to screen significant genes. ROC curve and multivariate Cox regression analysis were used to evaluate the prognostic value of multiple clinical features.Results In this study, 42 total DEGs were found, including 33 up-regulated genes and 9 down-regulated genes. GO analysis revealed that DEGs were involved in biological processes such as chromosomal segregation, nuclear division, and organelle fission. KEGG pathway analysis implicated Toll-like receptor and mismatch repair signaling pathways. 6 significant genes were identified by COX (p < 0.05) and CA9, GINS2, and SPP1 combined biomarkers divided cervical cancer patients into a high-risk group and a low-risk group. Moreover, the low-risk survival rate was significantly higher than the high-risk survival rate. Finally, multivariate Cox regression analysis showed that the combined biomarkers of CA9, GINS2, and SPP1 are independent predictors of the prognosis of cervical cancer patients.Conclusion The GEO and TCGA databases screened out the combined biomarkers of CA9, GINS2, and SPP1, which are independent prognostic predictors of cervical cancer.
Publisher
Research Square Platform LLC
Reference34 articles.
1. Impact of hypoxia on cervical cancer outcomes;Datta A;Int J Gynecol Cancer,2021
2. Global distribution, risk factors, and recent trends for cervical cancer: A worldwide country-level analysis;Huang J;Gynecol Oncol,2022
3. Human papillomavirus vaccination and cervical cancer risk;Rahangdale L;BMJ,2022
4. Screening for cervical cancer: Choices & dilemmas;Rajaram S;Indian J Med Res,2021
5. Advances in management of locally advanced cervical cancer;Musunuru HB;Indian J Med Res,2021